Purinergic receptors on blood platelets

Platelets

Volumn 7, Issue 5-6, 1996, Pages 261-267

  Gachet, C ^a,b   Hechler, B ^a   Leon C ^a   Vial, C ^a   Ohlmann, P ^a   Cazenave, J P ^a  

^a INSERM   (France)

^b NONE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENYLATE CYCLASE; CALCIUM ION; GUANINE NUCLEOTIDE BINDING PROTEIN; ION CHANNEL; IONOTROPIC RECEPTOR; METABOTROPIC RECEPTOR; PURINE P2 RECEPTOR; PURINE P2X RECEPTOR; PURINE P2Y RECEPTOR; PURINE RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; PURINERGIC RECEPTOR STIMULATING AGENT; RECEPTOR SUBTYPE; THROMBOCYTE RECEPTOR;

CALCIUM TRANSPORT; ENZYME INHIBITION; HEMOSTASIS; PRIORITY JOURNAL; REVIEW; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION;

EID: 0030474349     PISSN: 09537104     EISSN: None     Source Type: Journal    
DOI: 10.3109/09537109609023587     Document Type: Review

References (21)

1. Burnstock G. A basis for distinguishing two types of purinergic receptors. In: Bolis L, Straub RN, eds. Cell Membrane Receptors for Drugs and Hormones: A Multidisciplinary Approach. New York: Raven Press, 1978: 107-18.
2. Dubyac GR, El Moatassim C. Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides. Am J Physiol 1993; 265: C577-C606.
3. 2Y purinoceptors? Pharmacol Ther 1994; 64:445-75.
4. Burnstock G, King BF. The numbering of cloned P2 purinoceptors. Drug Dev Res 1996; 38: 67-71.
5. Hellem AJ. The adhesiveness of human blood platelets in vitro. Scand J Clin Lab Invest 1960; 12: 1-117.
6. Ollgaard E. Macroscopic studies of platelet aggregation: nature of an aggregating factor in red blood cells and platelets. Thromb Diath Haemorrh 1961; 6: 86-97.
7. Gaardner A, Jonsen J, Laland S, Hellem A, Owen PA. Adenosine diphosphate in red cells as a factor in the adhesiveness of human blood platelets. Nature 1961; 192:531-2.
8. Reimers HJ. Adenine nucleotides in blood platelets. In: Longenecker GL, ed. The Platelets: Physiology and Pharmacology. Orlando: Academic Press, 1985; 85-98.
9. Siess W. Molecular mechanisms of platelet activation. Physiol Rev 1989; 69: 58-178.
10. Born GVR. Adenosine diphosphate as a mediator of platelet aggregation in vivo: an editorial point of view. Circulation 1985; 72: 741-2.
11. Maffrand J-P, Bernat A, Delebassée D, Defreyn G, Cazenave J-P, Gordon JL. ADP plays a key role in thrombogenesis in rats. Thromb Haemost 1988; 59: 225-30.
12. Herbert JM, Frehel D, Vallee E, Kieffer G, Gouy D, Berger Y, Necciari J, Defreyn G, Maffrand JP. Clopidogrel, a novel antiplatelet and antithrombotic agent. Cardiovasc Drug Rev 1993; 11: 180-98.
13. Verry M, Panak E, Cazenave JP. Antiplatelet therapy in the prevention of ischaemic stroke. Nouv Rev Fr Hématol 1994; 36: 213-28.
14. 2T purinoceptor antagonists: definition of the role of ADP in arterial thrombosis. Trends Pharmacol Sci 1995; 16: 179-81.
15. Cattaneo M, Lecchi A, Randi AM, McGregor JL, Mannuci PM. Identification of a new congenital defect of platelet function characterized by severe impairment of platelet responses to adenosine diphosphate. Blood 1992; 80: 2787-96.
16. Nurden P, Savi P, Heilmann E, Bihour C, Herbert JM, Maffrand JP, Nurden A. An inherited bleeding disorder linked to a defective interaction between ADP and its receptor on platelets. J Clin Invest 1995; 95: 1612-22.
17. Di Minno G, Cerbonne AM, Mattioli PL, Turco S, Iovine C, Mancini M. Functionally thrombasthenic state in normal platelets following the administration of ticlopidine. J Clin Invest 1985; 75: 328-38.
18. Gachet C, Cattaneo M, Ohlmann P, Lecchi A, Hechler B, Chevalier J, Cassel D, Mannucci P, Cazenave J-P. Purinoceptors on blood platelets: further pharmacological and clinical evidence to suggest the presence of two ADP receptors. Br J Haematol 1995; 91: 434-44.
19. MacFarlane DE. Agonists and receptors: adenosine diphosphate. In: Holmsen H, ed. Responses and Metabolism. Boca Raton, FL: CRC Press, 1987: 19-36.
20. Mustard JF, Perry DW, Kinlough-Rathbone RL, Packham MA. Factors responsible for ADP-induced release reaction of human platelets. Am J Physiol 1975; 228: 1857-65.
21. 2 formation upon close contact of human platelets in media with a low concentration of ionized calculi. Blood 1987; 70: 647-51.